Srujan Marepally

1.7k total citations
60 papers, 1.3k citations indexed

About

Srujan Marepally is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Srujan Marepally has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 14 papers in Genetics and 8 papers in Infectious Diseases. Recurrent topics in Srujan Marepally's work include RNA Interference and Gene Delivery (30 papers), Virus-based gene therapy research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Srujan Marepally is often cited by papers focused on RNA Interference and Gene Delivery (30 papers), Virus-based gene therapy research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Srujan Marepally collaborates with scholars based in India, United States and France. Srujan Marepally's co-authors include Mandip Singh, Arabinda Chaudhuri, Apurva R. Patel, Chandrashekhar Voshavar, Pinaki R. Desai, Ravi Doddapaneni, Rajesh Mukthavaram, B. Sreedhar, Cedar H. A. Boakye and Rintu Banerjee‬‬‬‬‬‬‬‬‬ and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Srujan Marepally

57 papers receiving 1.3k citations

Peers

Srujan Marepally
Mara C. Ebeling United States
Benjamin Bruno United States
Srujan Marepally
Citations per year, relative to Srujan Marepally Srujan Marepally (= 1×) peers Susumu Hama

Countries citing papers authored by Srujan Marepally

Since Specialization
Citations

This map shows the geographic impact of Srujan Marepally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srujan Marepally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srujan Marepally more than expected).

Fields of papers citing papers by Srujan Marepally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srujan Marepally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srujan Marepally. The network helps show where Srujan Marepally may publish in the future.

Co-authorship network of co-authors of Srujan Marepally

This figure shows the co-authorship network connecting the top 25 collaborators of Srujan Marepally. A scholar is included among the top collaborators of Srujan Marepally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srujan Marepally. Srujan Marepally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kumar, Reetesh, et al.. (2024). Biogenically synthesized green silver nanoparticles exhibit antimalarial activity. SHILAP Revista de lepidopterología. 19(1). 136–136. 3 indexed citations
3.
Magis, Wendy, K. Manjunatha Prasad, Srujan Marepally, et al.. (2024). Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies. Stem Cell Research & Therapy. 15(1). 504–504. 1 indexed citations
4.
Taneja, Pankaj, et al.. (2024). Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B. Pharmaceutics. 16(11). 1427–1427.
5.
Rachamalla, Hari Krishnareddy, Mohammad Salma, Mahesh Moorthy, et al.. (2024). SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants. Molecular Therapy. 32(5). 1284–1297. 8 indexed citations
6.
Rani, S. Kutti, et al.. (2024). Base-modified factor VIII mRNA delivery with galactosylated lipid nanoparticles as a protein replacement therapy for haemophilia A. Biomaterials Science. 12(19). 5052–5062. 2 indexed citations
7.
Marepally, Srujan, et al.. (2024). Multiplexed RNAs in lipid nanoparticles: potential therapeutic vaccine for chronic hepatitis B. Signal Transduction and Targeted Therapy. 9(1). 312–312. 1 indexed citations
8.
Premkumar, Prasanna Samuel, et al.. (2022). Omicron infection increases IgG binding to spike protein of predecessor variants. Journal of Medical Virology. 95(2). e28419–e28419. 6 indexed citations
9.
Rachamalla, Hari Krishnareddy, Saravanabhavan Thangavel, Kumarasamypet M. Mohankumar, et al.. (2022). Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System. Frontiers in Pharmacology. 13. 840727–840727. 6 indexed citations
10.
Marepally, Srujan, et al.. (2022). Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells. Journal of Visualized Experiments. 4 indexed citations
11.
Prasad, K. Manjunatha, J. B. Paul, Yukio Nakamura, et al.. (2022). Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2. SHILAP Revista de lepidopterología. 4. 1085111–1085111. 1 indexed citations
12.
Rajagopal, Karthikeyan, et al.. (2021). Controlled Differentiation of Mesenchymal Stem Cells into Hyaline Cartilage in miR-140-Activated Collagen Hydrogel. Cartilage. 13(2_suppl). 571S–581S. 10 indexed citations
13.
Srinivasan, Saranya, Sanjay Kumar, Srujan Marepally, et al.. (2021). Preferential Expansion of Human CD34 + CD133 + CD90 + Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene Therapy. Human Gene Therapy. 33(3-4). 188–201. 10 indexed citations
14.
Puppala, Eswara Rao, Basveshwar Gawali, Amit Alexander, et al.. (2021). Lithocholic acid-tryptophan conjugate (UniPR126) based mixed micelle as a nano carrier for specific delivery of niclosamide to prostate cancer via EphA2 receptor. International Journal of Pharmaceutics. 605. 120819–120819. 28 indexed citations
15.
Rangasami, Vignesh Kumar, Chandrashekhar Voshavar, Hari Krishnareddy Rachamalla, et al.. (2018). Exploring membrane permeability of Tomatidine to enhance lipid mediated nucleic acid transfections. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1861(1). 327–334. 8 indexed citations
16.
Voshavar, Chandrashekhar, Vignesh Kumar Rangasami, Shaji R Velayudhan, et al.. (2017). An anti-oxidant, α-lipoic acid conjugated oleoyl- sn -phosphatidylcholineas a helper lipid in cationic liposomal formulations. Colloids and Surfaces B Biointerfaces. 152. 133–142. 9 indexed citations
17.
Boakye, Cedar H. A., Ketan Patel, Ravi Doddapaneni, et al.. (2016). Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment. Journal of Controlled Release. 246. 120–132. 62 indexed citations
18.
Andey, Terrick, Apurva R. Patel, Srujan Marepally, et al.. (2016). Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine. PLoS ONE. 11(1). e0146804–e0146804. 13 indexed citations
19.
Tyagi, Rajeev K., Neeraj Garg, Rajesh S. Jadon, et al.. (2015). Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119. Vaccine. 33(36). 4630–4638. 46 indexed citations
20.
Desai, Pinaki R., Srujan Marepally, Apurva R. Patel, et al.. (2013). Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo. Journal of Controlled Release. 170(1). 51–63. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026